간편결제 가능보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
H1N1 백신 시장. H1N1 백신 시장 규모는 2027 년까지 23 억 달러에이를 것으로 예상되며, 예측 기간 2022-2027 년 동안 CAGR 4.51%로 증가합니다. H1N1 인플루엔자 바이러스 또는 돼지 H1N1 바이러스는 H1N1 또는 일반적으로 돼지 독감이라고하는 인간에서 발생하는 감염성 질환의 원인입니다
Summary
H1N1 Vaccine Market. H1N1 Vaccine Market size is forecast to reach $2.3 billion by 2027, growing at a CAGR of 4.51% during the forecast period 2022-2027. H1N1 influenza virus or swine H1N1 virus is a causative agent of infectious disease caused in human beings known as H1N1 or commonly referred to as swine flu
Table of Contents
1. H1N1 Vaccine Market - Overview
1.1 Definitions and Scope
2. H1N1 Vaccine Market - Executive Summary
2.1 Market Revenue and Key Trends by Company
2.2 Key trends by Vaccine Type
2.3 Key trends by Type of Brand
2.4 Key trends by Geography
3. H1N1 Vaccine Market – Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split by Key Companies
3.4 Patent Analysis – Key Companies
3.5 Pricing Analysis
4. H1N1 Vaccine Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters five force model
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5. H1N1 Vaccine Market – Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. H1N1 Vaccine Market – By Vaccine Type (Market Size –$Million/$Billion)
6.1 Intranasal
6.2 Conjugate
6.3 Attenuated Vaccines
6.4 Inactivated Vaccine
6.5 Intramuscular
6.6 Toxoid
6.7 Others
7. H1N1 Vaccine Market – By Type of Brand (Market Size –$Million/$Billion)
7.1 Agripal
7.2 Fiuarix
7.3 Influgen
7.4 Influvac
7.5 Nasovac
7.6 Vaxigrip
7.7 Other
8. H1N1 Vaccine Market - By Geography
8.1 North America
8.1.1 U.S.
8.1.2 Mexico
8.1.3 Canada
8.2 Europe
8.2.1 U.K.
8.2.2 France
8.2.3 Germany
8.2.4 Italy
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 China
8.3.2 India
8.3.3 Japan
8.3.4 South Korea
8.3.5 Australia
8.3.6 New Zealand
8.3.7 Rest of APAC
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Africa
8.4.3 South America
9. H1N1 Vaccine Market - Entropy
10. H1N1 Vaccine Market Company Analysis
10.1 Company 1
10.2 Company 2
10.3 Company 3
10.4 Company 4
10.5 Company 5
10.6 Company 6
10.7 Company 7
10.8 Company 8
10.9 Company 9
10.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
세금계산서 발행 문의
T. 070 8015 5940
보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
H1N1 백신 시장. H1N1 백신 시장 규모는 2027 년까지 23 억 달러에이를 것으로 예상되며, 예측 기간 2022-2027 년 동안 CAGR 4.51%로 증가합니다. H1N1 인플루엔자 바이러스 또는 돼지 H1N1 바이러스는 H1N1 또는 일반적으로 돼지 독감이라고하는 인간에서 발생하는 감염성 질환의 원인입니다
Summary
H1N1 Vaccine Market. H1N1 Vaccine Market size is forecast to reach $2.3 billion by 2027, growing at a CAGR of 4.51% during the forecast period 2022-2027. H1N1 influenza virus or swine H1N1 virus is a causative agent of infectious disease caused in human beings known as H1N1 or commonly referred to as swine flu
Table of Contents
1. H1N1 Vaccine Market - Overview
1.1 Definitions and Scope
2. H1N1 Vaccine Market - Executive Summary
2.1 Market Revenue and Key Trends by Company
2.2 Key trends by Vaccine Type
2.3 Key trends by Type of Brand
2.4 Key trends by Geography
3. H1N1 Vaccine Market – Comparative Analysis
3.1 Product Benchmarking – Key Companies
3.2 Financial Analysis – Key Companies
3.3 Market Value Split by Key Companies
3.4 Patent Analysis – Key Companies
3.5 Pricing Analysis
4. H1N1 Vaccine Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters five force model
4.3.1 Bargaining power of suppliers
4.3.2 Bargaining powers of customers
4.3.3 Threat of new entrants
4.3.4 Rivalry among existing players
4.3.5 Threat of substitutes
5. H1N1 Vaccine Market – Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. H1N1 Vaccine Market – By Vaccine Type (Market Size –$Million/$Billion)
6.1 Intranasal
6.2 Conjugate
6.3 Attenuated Vaccines
6.4 Inactivated Vaccine
6.5 Intramuscular
6.6 Toxoid
6.7 Others
7. H1N1 Vaccine Market – By Type of Brand (Market Size –$Million/$Billion)
7.1 Agripal
7.2 Fiuarix
7.3 Influgen
7.4 Influvac
7.5 Nasovac
7.6 Vaxigrip
7.7 Other
8. H1N1 Vaccine Market - By Geography
8.1 North America
8.1.1 U.S.
8.1.2 Mexico
8.1.3 Canada
8.2 Europe
8.2.1 U.K.
8.2.2 France
8.2.3 Germany
8.2.4 Italy
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 China
8.3.2 India
8.3.3 Japan
8.3.4 South Korea
8.3.5 Australia
8.3.6 New Zealand
8.3.7 Rest of APAC
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Africa
8.4.3 South America
9. H1N1 Vaccine Market - Entropy
10. H1N1 Vaccine Market Company Analysis
10.1 Company 1
10.2 Company 2
10.3 Company 3
10.4 Company 4
10.5 Company 5
10.6 Company 6
10.7 Company 7
10.8 Company 8
10.9 Company 9
10.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
